Publication Topic

Zhao QJ, Haber L, Kohrman-Vincent M, Nance P, Dourson M. 2010. Quantitative modeling in noncancer risk assessment. In: Krishnan K, Andersen ME (eds), Quantitative modeling in toxicology. John Wiley & Sons Ltd.

Maier A, Kohrman-Vincent M, Parker A, Haber LT. 2010. Evaluation of concentration-response options for diacetyl in support of occupational risk assessment. Regul Toxicol Pharmacol 58(2):285–296.

Dourson M, Kohrman-Vincent M, Allen B, Cain W. 2010. Dose response assessment from effects of acute exposure to methyl isothiocyanate (MITC). Regul Toxicol Pharmacol 58(2):181–188.

Cain WS, Dourson ML, Kohrman-Vincent MJ, Allen BC. 2010. Human chemosensory perception of methyl isothiocyanate: Odor and chemesthesis. Regul Toxicol Pharmacol 58(2):173–180.

DeSantis AS, Hahn RA, Beloni JA, Gerecke DR, Svoboda KKH, Gordon MK. 2010. ADAM17/TACE inhibitors attenuate vesicant-induced epithelial-stromal separations. Association for Research in Vision and Ophthalmology (ARVO), Program #4783 (oral presentation).

DeSantis AS, Hahn RA, Gallo MA, Gerecke DR, Babin MC, Gordon MA. 2010. Amino plex as a countermeasure against vesicant exposure of rabbit corneas. 17th Biennial Medical Defense Bioscience Review meeting (May 2010, Hunt Valley, MD). In: Proceedings of the US Army Medical Defense Bioscience Review: A095.

Xue C-B, Chen L, Cao G, … Keller D, et al. 2010. Discovery of INCB9471, a potent, selective, and orally bioavailable CCR5 antagonist with potent anti-HIV-1 activity. ACS Med Chem Lett 1(9):483–487, doi: 10.1021/ml1001536.

Mueser TC, Hinerman JM, Devos JM, Boyer RA, Williams KJ. 2010. Structural analysis of bacteriophage T4 DNA replication: Review in the Virology Journal series on bacteriophage T4 and its relatives. Virol J 7:359.

Yu K, Covington T, Ruark C, Sterner T, Hack E, Gearhart J. A physiologically based pharmacokinetic model for pralidoxime in the guinea pig and in human. Presentation at the Chemical and Biological Defense Science and Technology Conference, Dallas, TX, November 2009.

Covington TR, Jakubowski EM, McGuire JM, Byers CE, Evans RA, Hulet SW, et al. A multi-species and -route ion- and isomer-specific physiologically-based pharmacokinetic-pharmacodynamic model for VX. Presentation at the Chemical and Biological Defense Science and Technology Conference, Dallas, TX, November 2009.

Panko JM. Progress on a BEEL Guide for d-limonene. Roundtable #224, American Industrial Hygiene Conference and Exhibition, Toronto, ON, June 2009.

Panko JM, Gaffney SH, Kreider ML, Unice KM, Burns AM, Paustenbach DJ, Booher LE, Gelatt RH. Job and task based analysis of benzene air concentrations associated with refinery operations. Benzene 2009: Health Effects and Mechanisms of Bone Marrow Toxicity; Implications for t-AML and the Mode of Action Framework, Munich, Germany, September 2009.

Williams ES, Panko JM, Paustenbach DJ. 2009. The European Union’s REACH Regulation: A review of its history and requirements. Crit Rev Toxicol 39(7):553–575; doi: 10.1080/10408440903036056.

Panko JM, Gaffney SH, Burns AM, Unice KM, Kreider ML, Booher LE, Gelatt RH, Marshall JR, Paustenbach DJ. 2009. Occupational exposure to benzene at the ExxonMobil Refinery at Baton Rouge, Louisiana (1977–2005). J Occup Environ Hyg 6(9):517–529. doi: 10.1080/15459620903044161.

Lea IA, Jackson MA, Dunnick JK. 2009. Genetic pathways to colorectal cancer. Mutat Res 670(1–2):96–98.

Covington TR, Jakubowski EM, McGuire JM, Evans RA, Hulet SW, Gearhart JM. Accounting for stereo-isomers and ionization in a PBPK/PD model of VX exposure. Poster presented at the Society of Toxicology Annual Meeting, Baltimore, MD, March 2009.

DeSantis AS, Hahn RA, Beloni J, Svoboda KKH, Gerecke DR, Babin M, Gordon MK. 2009. Countermeasures against nitrogen mustard injury to the cornea. Society of Toxicology, Abstract #547.

DeSantis AS, Hahn RA, Beloni JA, Schultz G, Heindel N, Svoboda KKH, Babin MC, Gerecke DR, Gordon MK. 2009. Healing of corneal wounds induced by vesicants. FASEB J. 23:469.2.

DeSantis AS, Hahn RA, Beloni J, Gerecke DR, Svoboda KKH, Gordon MK, Schultz G. 2009. Corneal vesicant injury is ameliorated by matrix metalloproteinase inhibitors. Association for Research in Vision and Ophthalmology (ARVO), Program #3064 (oral presentation).